Bavarian Nordic raises sales guidance after monkeypox vaccine order By Reuters


© Reuters. FILE PHOTO: An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. The company, headquartered in Denmark, is the only one in the world to have approval for a smallpox vacc

COPENHAGEN (Reuters) – Danish biotechnology company Bavarian Nordic on Wednesday lifted its sales outlook and now expects a smaller operating loss this year after signing a contract with an undisclosed country for the supply of its monkeypox vaccine.

Be the first to comment

Leave a Reply

Your email address will not be published.


*